Humana stock gains 3.53 percent to EUR 381.00 after hours

Published on 10/20/2026 at 18:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Baird raised its target to USD 596 on October 9, 2026. Humana stock costs EUR 381.00 on October 20, 2026 at 6:34 p.m. CEST, up 3.53 percent versus the Tradegate close.

Key dates and valuation

Baird raised its Humana target from USD 390.00 to USD 596.00 on October 9, 2026.
Second-quarter revenue reached USD 40.87 billion, up 26.20 percent from the prior year.
Humana stock costs EUR 381.00 at Lang & Schwarz on October 20, 2026 at 6:34 p.m. CEST, 3.53 percent above the Tradegate close of October 19, 2026.
Humana is scheduled to report third-quarter 2026 results on November 6, 2026.

Zwei Ingenieure in Schutzhelmen vor Prozess-Kontrollbildschirm in Industrieanlage — Honeywell US4448591028 Ingenieure überwachen industrielle Automatisierungsanlage mit digitalen Prozessanzeigen im modernen Kontrollraum, Illustration mit AI erstellt.

Humana (ISIN US4448591028) stock stood 3.53 percent above the Tradegate close of October 19, 2026, at EUR 381.00 at Lang & Schwarz on October 20, 2026. The price event gives the latest analyst target a clear market backdrop. According to GetCoattail, Robert W. Baird raised its target for Humana from USD 390.00 to USD 596.00 on October 9, 2026. Humana stock was trading at EUR 381.00 at Lang & Schwarz on October 20, 2026 at 6:34 p.m. CEST.

Revenue reached USD 40.87 billion

The latest reported operating figures provide the second anchor for the share move. In the second quarter of 2026, Humana generated USD 40.87 billion in revenue, an increase of 26.20 percent from the same quarter a year earlier. MarketBeat reported that quarterly earnings per share were USD 7.61, ahead of the USD 7.27 consensus, while revenue exceeded the USD 40.58 billion estimate.

Stock stays below its yearly high

The primary listing is on the NYSE under ticker HUM. Humana last traded at USD 428.72 on October 20, 2026 at 12:41 p.m. ET. Its market capitalization was USD 51.5 billion, and its 52-week range was USD 163.11 to USD 456.50. The current primary-market price was 6.07 percent below the 52-week high.

What does USD 596 imply?

Measured against the USD 428.72 NYSE price, the Baird target of USD 596.00 stands 39.00 percent above the stock. That comparison puts the analyst view well above the current market level, while Humana's price-to-earnings ratio stood at 40.63.

Humana's next scheduled reporting date is November 6, 2026, when it will release third-quarter 2026 results. The company's investor-relations calendar also lists a virtual investor update for December 10, 2026, according to Humana.

Humana stock and the next dates

The November report will show whether the second-quarter revenue growth and improved Medicare Advantage ratings are translating into the earnings profile behind the latest target increases. For investors, the key comparison is between the USD 596.00 Baird target and the company's next reported quarter.

Humana stock was trading at EUR 381.00 at Lang & Schwarz on October 20, 2026 at 6:34 p.m. CEST, up 3.53 percent versus the Tradegate close of October 19, 2026 at EUR 368.00. The further course of trading is shown by the continuously updated real-time quote of Humana stock.